Recurrent Stage IV High Risk Neuroblastoma
1 clinical trials · Condition
◉ Watch Recurrent Stage IV High Risk Neuroblastoma
| Record | Firm | Date |
|---|---|---|
| Study on Sintilimab in Stage IV High Risk Neuroblastoma (NCT04412408) | Shanghai Children's Medical Center | 2020-09-01 |
Track Recurrent Stage IV High Risk Neuroblastoma automatically
Every clearance here is in the API, with alerts when new ones post.